✦ LIBER ✦

Optimal distance of malignant negative margin in excision of nonsmall cell lung cancer: a multicenter prospective study

✍ Scribed by Noriyoshi Sawabata; Mitsunori Ohta; Akihide Matsumura; Katsuhiro Nakagawa; Hiroshi Hirano; Hajime Maeda; Hikaru Matsuda

Book ID: 117036701
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 100 KB
Volume: 77
Category: Article
ISSN: 0003-4975
DOI: 10.1016/s0003-4975(03)01511-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic value of cytokeratin-positive

Prognostic value of cytokeratin-positive cells in the bone marrow and lymph nodes of patients with resected nonsmall cell lung cancer: a multicenter prospective study

✍ Kosei Yasumoto; Toshihiro Osaki; Yoh Watanabe; Harubumi Kato; Takesumi Yoshimura 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Assessment of palliative care for advanc

Assessment of palliative care for advanced non-small-cell lung cancer in France: A prospective observational multicenter study (GFPC 0804 study)

✍ Vergnenègre, Alain; Hominal, Stéphane; Tchalla, Achille Edem; Bérard, Henri; Mon 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 494 KB

O-87 Duration of chemotherapy and surviv

O-87 Duration of chemotherapy and survival in advanced non-small cell lung cancer (NSCLC). A multicenter, prospective randomised study

✍ Andresen, Olga; Sörenson, Sverre; Bergman, Bengt; Sundstrøm, Stein; Vilsvik, Jan 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 355 KB

Prospective randomized study of four nov

Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma : A Minnie Pearl Cancer Research Network trial

✍ F. Anthony Greco; James R. Gray Jr.; Dana S. Thompson; Howard A. Burris III; Joa 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

## Abstract ## BACKGROUND The authors compared the toxicity, response rate, and progression free survival of four chemotherapy regimens for patients with advanced (Stage IIIB and IV) nonsmall cell lung carcinoma. ## METHODS A total of 267 patients entered this randomized Phase II trial on one of

Clinical prognostic factors (PF) for sur

Clinical prognostic factors (PF) for survival in non small cell lung cancer (SCLC). Can they add something new? Results of a prospective multicenter study

✍ Fuentes, R.; Bover, I.; Rifa, J.; Moreno, V.; Canals, E.; Marquez, A.; Molina, R 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 289 KB

O-229 Prognostic value of cytokeratin-po

O-229 Prognostic value of cytokeratin-positive cells in the bone marrow and lymph nodes of patients with resected non-small cell lung cancer: a multicenter prospective study

✍ Sugio, Kenji; Osaki, Toshihiro; Watanabe, Yoh; Kato, Harufumi; Mitsudomi, Tetsuy 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 317 KB